Clinical Trials Workshop

This 2-day workshop will provide a forum for information exchange and discussion on conceptual and practical questions through lectures and panel discussions.There will be a particular focus on the critical issues affecting sponsors and Member States as they consider the impact and changes needed to implement the regulation.

Back to Agenda

Pre-Workshop Session: Overview on CT Regulation

Session Chair(s)

Clare Lavery, MSc

Pharmacovigilance Excellence Principal

AstraZeneca, United Kingdom

There will be an optional training session at the start of the Workshop outlining the key provisions of the Clinical Trial Regulation and the knowledge about the CTReg that is widely known (potentially it will include provisions in any released delegated acts (GMP and/or GCP) and implementing guidance).

Speaker(s)

Fabienne Zeegers, DrSc, MSc

Bristol Myers Squibb International, Belgium

Director, Global Regulatory Sciences Liaison and Strategy

Have an account?